KBL Merger Corp. IV (KBLM)

Home » Stocks » KBLM

Nov 9, 2020 - Stock symbol was changed to ATNF

Stock Price: $4.99 USD 0.00 (0.00%)

Updated Nov 6, 2020 4:00 PM EST

• Overview
• Financials

Key Info

Market Cap	26.81M
Revenue (ttm)	n/a
Net Income (ttm)	-2.84M
Shares Out	5.47M
EPS (ttm)	-0.65
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Dividend Yield	n/a

Stock Quote

Trading Day	Nov 6, 2020
Last Price	$4.99
Previous Close	$4.99
Change ($)	0.00
Change (%)	0.00%
Day's Open	6.04
Day's Range	4.60 - 6.05
Day's Volume	160,754
52-Week Range	4.60 - 11.50

More Stats

Market Cap	26.81M
Enterprise Value	26.53M
Earnings Date (est)	n/a
Ex-Dividend Date	n/a
Shares Outstanding	5.47M
Float	n/a
EPS (basic)	-0.65
EPS (diluted)	-0.65
FCF / Share	-0.30

Dividend	n/a
Dividend Yield	n/a
Earnings Yield	n/a
FCF Yield	n/a
Payout Ratio	n/a
Shares Short	1,256
Short Ratio	1.11
Short % of Float	n/a
Beta	0.18

PE Ratio	n/a
Forward PE	n/a
P/FCF Ratio	n/a
PS Ratio	n/a
PB Ratio	6.54
Revenue	n/a
Operating Income	-1.28M
Net Income	-2.84M
Free Cash Flow	-1.32M

Net Cash	276,420
Net Cash / Share	0.05
Gross Margin	n/a
Operating Margin	n/a
Profit Margin	n/a
FCF Margin	n/a
ROA	-2.55%
ROE	-56.82%
ROIC	-12.80%

Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (0)

Buy	0
Overweight	0
Hold	0
Underweight	0
Sell	0

What these ratings mean

Analyst Consensus: n/a

Price Target

$n/a*

*No analysts have provided price targets for this stock.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Income Statement | Balance Sheet | Cash Flow | Ratios

Year	2019	2018	2017
Revenue	-	-	-
Operating Income	-1.21	-0.60	-0.34
Net Income	-0.09	1.04	0.12
Shares Outstanding	4.22	4.17	3.45
Earnings Per Share	-0.02	0.07	0.01
EPS Growth	-	600%	-
Operating Cash Flow	-1.45	-0.79	-0.50
Free Cash Flow	-1.45	-0.79	-0.50
Cash & Equivalents	0.55	0.27	0.43
Total Debt	0.37	-	-
Net Cash / Debt	0.18	0.27	0.43
Assets	12.50	118	117
Liabilities	7.15	4.57	4.23
Book Value	5.00	5.00	5.00

Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name	KBL Merger Corp. IV
Country	United States
CEO	Marlene R. Krauss

Stock Information

Ticker Symbol	KBLM
Stock Exchange	NASDAQ
Sector	Financial Services
Industry	Shell Companies
Unique Identifier	NASDAQ: KBLM
IPO Date	June 2, 2017

Description

KBL Merger IV is a private equity firm specializing in acquisition, buyout, PIPES and secondaries investments. The firm seeks to invest in healthcare or the healthcare-related wellness industry. In healthcare services the firm seeks to invest in outpatient care, physician practices, behavioral health and payor services. In pharma services the firm seeks to invest in outsourced services, contract research and generics / OTC. In health IT the firm seeks to invest in EMR / HER, revnue cycle management, telemedicine and care management. In minimal reimbursement risk the firm focuses on retail healthcare, wellness and preventative care. In devices and diagnostics the firm focuses on medical devices, diagnostics, genetic testing and lab tools. The firm typically invests in firms located in the United States. The firm seeks to invest in firms with valuation between $200 million to $700 million and EBITDA between $20 million to $70 million. The firms invest in firms with enterprise value $200 million to $700 million. The firm seeks to take majority stakes. KBL Merger Corp. IV was founded in 2016 and is New York, New York with an additional office in Newark, Delaware.